Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

An Overview of Treatment Modalities and Management Aspects for Obesity

Author(s): Mohit Kumar, Md Sadique Hussain, Sonu, Sakshi Raj, Rahul Verma, Sakshi Sharma and Sanjeev Kumar Sahu*

Volume 19, Issue 2, 2023

Published on: 15 August, 2022

Page: [105 - 113] Pages: 9

DOI: 10.2174/1573401318666220527124759

Price: $65

Abstract

Background: Obesity is a prominent disorder that has a drastic effect on lots of individuals. It is a consequence of non-equilibrium in the energy expenditure and intake of energy, while other etiological factors can be genetic, epigenetic, and physiological.

Objective: The aim is to explore the multiple aspects reported for its management based on controlled metabolic approaches as well as surgical approaches.

Results: It has been reviewed that medical interventions for obesity are lifestyle-altering interventions that include appropriate diet and exercise. Furthermore, pharmacotherapy is also proving to be efficient for the management of obesity. Drugs allowed by the competent authority of the US are for long-term such as orlistat and phentermine for the short-term obesity treatment. Surgical approaches involve restrictive, malabsorptive as well as mixed bariatric procedures and these procedures show evidence to alleviate obesity and its comorbidities.

Conclusion: This review explored various treatment options for obesity.

Keywords: Obesity, nutrition, treatment modalities, management, orlistat, bariatric procedures.

Next »
[1]
Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89(6): 2583-9.
[http://dx.doi.org/10.1210/jc.2004-0535] [PMID: 15181027]
[2]
Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: A quantitative systematic review. Obes Rev 2011; 12(1): 50-61.
[http://dx.doi.org/10.1111/j.1467-789X.2009.00708.x] [PMID: 20059703]
[3]
Finkelstein EA, Graham WCK, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics 2014; 133(5): 854-62.
[http://dx.doi.org/10.1542/peds.2014-0063] [PMID: 24709935]
[4]
Bray GA. Diabetes and obesity--Time bombs to be defused. Diabetes Care 2015; 38(11): 1997-9.
[http://dx.doi.org/10.2337/dci15-0008] [PMID: 26494806]
[5]
Cawley J, Meyerhoefer C. The medical care costs of obesity: An instrumental variables approach. J Health Econ 2012; 31(1): 219-30.
[http://dx.doi.org/10.1016/j.jhealeco.2011.10.003] [PMID: 22094013]
[6]
Loeppke R, Taitel M, Haufle V, Parry T, Kessler RC, Jinnett K. Health and productivity as a business strategy: A multiemployer study. J Occup Environ Med 2009; 51(4): 411-28.
[http://dx.doi.org/10.1097/JOM.0b013e3181a39180] [PMID: 19339899]
[7]
Janesick AS, Shioda T, Blumberg B. Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol 2014; 398(1-2): 31-5.
[http://dx.doi.org/10.1016/j.mce.2014.09.002] [PMID: 25218215]
[8]
Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: Exploring the roads less traveled. Int J Obes 2006; 30(11): 1585-94.
[http://dx.doi.org/10.1038/sj.ijo.0803326] [PMID: 16801930]
[9]
Shepherd TM. Effective management of obesity. J Fam Pract 2003; 52(1): 34-42.
[PMID: 12540311]
[10]
Shukla AP, Buniak WI, Aronne LJ. Treatment of obesity in 2015. J Cardiopulm Rehabil Prev 2015; 35(2): 81-92.
[http://dx.doi.org/10.1097/HCR.0000000000000112] [PMID: 25714749]
[11]
Hussain SS, Bloom SR. The pharmacological treatment and management of obesity. Postgrad Med 2011; 123(1): 34-44.
[http://dx.doi.org/10.3810/pgm.2011.01.2243] [PMID: 21293082]
[12]
Fujioka K. Management of obesity as a chronic disease: Nonpharmacologic, pharmacologic, and surgical options. Obes Res 2002; 10(S12) (Suppl. 2): 116S-23S.
[http://dx.doi.org/10.1038/oby.2002.204] [PMID: 12490660]
[13]
Nammi S, Koka S, Chinnala KM, Boini KM. Obesity: An overview on its current perspectives and treatment options. Nutr J 2004; 3(1): 3.
[http://dx.doi.org/10.1186/1475-2891-3-3] [PMID: 15084221]
[14]
Wing RR, Jeffery RW. Food provision as a strategy to promote weight loss. Obes Res 2001; 9(S11) (Suppl. 4): 271S-5S.
[http://dx.doi.org/10.1038/oby.2001.130] [PMID: 11707553]
[15]
Witkin M. Management of obesity. S Afr Med J 1956; 30(20): 465-6.
[PMID: 13324413]
[16]
Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360(9): 859-73.
[http://dx.doi.org/10.1056/NEJMoa0804748] [PMID: 19246357]
[17]
Hu T, Mills KT, Yao L, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2012; 176 (Suppl. 7): S44-54.
[http://dx.doi.org/10.1093/aje/kws264] [PMID: 23035144]
[18]
Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis. JAMA 2014; 312(9): 923-33.
[http://dx.doi.org/10.1001/jama.2014.10397] [PMID: 25182101]
[19]
Huo R, Du T, Xu Y, et al. Effects of mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: A meta-analysis. Eur J Clin Nutr 2015; 69(11): 1200-8.
[http://dx.doi.org/10.1038/ejcn.2014.243] [PMID: 25369829]
[20]
Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368(14): 1279-90.
[http://dx.doi.org/10.1056/NEJMoa1200303] [PMID: 23432189]
[21]
Ashley JM, St Jeor ST, Schrage JP, et al. Weight control in the physician’s office. Arch Intern Med 2001; 161(13): 1599-604.
[http://dx.doi.org/10.1001/archinte.161.13.1599] [PMID: 11434791]
[22]
Greenwald A. Current nutritional treatments of obesity. Adv Psychosom Med 2006; 27: 24-41.
[http://dx.doi.org/10.1159/000090961] [PMID: 16418540]
[23]
King AC, Haskell WL, Taylor CB, Kraemer HC, DeBusk RF. Group- vs. home-based exercise training in healthy older men and women. A community-based clinical trial. JAMA 1991; 266(11): 1535-42.
[http://dx.doi.org/10.1001/jama.1991.03470110081037] [PMID: 1880885]
[24]
Burke LE, Styn MA, Glanz K, et al. SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings. Contemp Clin Trials 2009; 30(6): 540-51.
[http://dx.doi.org/10.1016/j.cct.2009.07.003] [PMID: 19665588]
[25]
Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr 1997; 66(2): 239-46.
[http://dx.doi.org/10.1093/ajcn/66.2.239] [PMID: 9250100]
[26]
Pavlou KN, Krey S, Steffee WP. Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr 1989; 49(5) (Suppl.): 1115-23.
[http://dx.doi.org/10.1093/ajcn/49.5.1115] [PMID: 2655416]
[27]
Blair SN. Evidence for success of exercise in weight loss and control. Ann Intern Med 1993; 119(7 Pt 2): 702-6.
[http://dx.doi.org/10.7326/0003-4819-119-7_Part_2-199310011-00015] [PMID: 8363201]
[28]
Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the centers for disease control and prevention and the american college of sports medicine. JAMA 1995; 273(5): 402-7.
[http://dx.doi.org/10.1001/jama.1995.03520290054029] [PMID: 7823386]
[29]
Satcher DS. Executive summary: A report of the surgeon general on mental health. Public Health Rep 2000; 115(1): 89-101.
[http://dx.doi.org/10.1093/phr/115.1.89] [PMID: 10968589]
[30]
Burke LE, Wang J. Treatment strategies for overweight and obesity. J Nurs Scholarsh 2011; 43(4): 368-75.
[http://dx.doi.org/10.1111/j.1547-5069.2011.01424.x] [PMID: 22018175]
[31]
Labib M. acp Best Practice No 168. The investigation and management of obesity. J Clin Pathol 2003; 56(1): 17-25.
[http://dx.doi.org/10.1136/jcp.56.1.17] [PMID: 12499427]
[32]
Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association. Circulation 2010; 122(4): 406-41.
[http://dx.doi.org/10.1161/CIR.0b013e3181e8edf1] [PMID: 20625115]
[33]
Butryn ML, Phelan S, Hill JO, Wing RR. Consistent self-monitoring of weight: A key component of successful weight loss maintenance. Obesity 2007; 15(12): 3091-6.
[http://dx.doi.org/10.1038/oby.2007.368] [PMID: 18198319]
[34]
Kanfer FH. Self-Monitoring: Methodological limitations and clinical applications. J Consult Clin Psychol 1970; 35(2): 148-50.
[http://dx.doi.org/10.1037/h0029874]
[35]
Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin North Am 2005; 28(1): 151-70.
[http://dx.doi.org/10.1016/j.psc.2004.09.008] [PMID: 15733617]
[36]
Wing RR. Behavioral approaches to the treatment of obesity handbook of obesity: clinical applications. NY: Marcel Dekker New York 2004; Vol. 2: pp. 147-67.
[37]
Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005; 353(20): 2111-20.
[http://dx.doi.org/10.1056/NEJMoa050156] [PMID: 16291981]
[38]
Glasgow RE, Goldstein MG, Ockene JK, Pronk NP. Translating what we have learned into practice. Principles and hypotheses for interventions addressing multiple behaviors in primary care. Am J Prev Med 2004; 27(2) (Suppl.): 88-101.
[http://dx.doi.org/10.1016/j.amepre.2004.04.019] [PMID: 15275677]
[39]
Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. (2nd ed.), New York, NY, US: The Guilford Press 2002.
[40]
Wadden TA. New goals of obesity treatment: A healthier weight and other ideals. Prim Psychiatry 1998; 5: 45-54.
[41]
Wadden TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol 1994; 62(1): 165-71.
[http://dx.doi.org/10.1037/0022-006X.62.1.165] [PMID: 8034818]
[42]
Perri MG, McAllister DA, Gange JJ, Jordan RC, McAdoo G, Nezu AM. Effects of four maintenance programs on the long-term management of obesity. J Consult Clin Psychol 1988; 56(4): 529-34.
[http://dx.doi.org/10.1037/0022-006X.56.4.529] [PMID: 2848874]
[43]
Vainik U, Dagher A, Dubé L, Fellows LK. Neurobehavioural correlates of body mass index and eating behaviours in adults: A systematic review. Neurosci Biobehav Rev 2013; 37(3): 279-99.
[http://dx.doi.org/10.1016/j.neubiorev.2012.11.008] [PMID: 23261403]
[44]
Kringelbach ML, de Araujo IET, Rolls ET. Taste-related activity in the human dorsolateral prefrontal cortex. Neuroimage 2004; 21(2): 781-8.
[http://dx.doi.org/10.1016/j.neuroimage.2003.09.063] [PMID: 14980581]
[45]
Gautier JF, Del Parigi A, Chen K, et al. Effect of satiation on brain activity in obese and lean women. Obes Res 2001; 9(11): 676-84.
[http://dx.doi.org/10.1038/oby.2001.92] [PMID: 11707534]
[46]
Gautier JF, Chen K, Salbe AD, et al. Differential brain responses to satiation in obese and lean men. Diabetes 2000; 49(5): 838-46.
[http://dx.doi.org/10.2337/diabetes.49.5.838] [PMID: 10905495]
[47]
Tataranni PA, Gautier JF, Chen K, et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 1999; 96(8): 4569-74.
[http://dx.doi.org/10.1073/pnas.96.8.4569] [PMID: 10200303]
[48]
DelParigi A, Chen K, Salbe AD, et al. Persistence of abnormal neural responses to a meal in postobese individuals. Int J Obes 2004; 28(3): 370-7.
[http://dx.doi.org/10.1038/sj.ijo.0802558] [PMID: 14676847]
[49]
Le DSNT, Pannacciulli N, Chen K, et al. Less activation of the left dorsolateral prefrontal cortex in response to a meal: A feature of obesity. Am J Clin Nutr 2006; 84(4): 725-31.
[http://dx.doi.org/10.1093/ajcn/84.4.725] [PMID: 17023697]
[50]
Le DSNT, Pannacciulli N, Chen K, et al. Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss. Am J Clin Nutr 2007; 86(3): 573-9.
[http://dx.doi.org/10.1093/ajcn/86.3.573] [PMID: 17823419]
[51]
Le DSNT, Chen K, Pannacciulli N, et al. Reanalysis of the obesity-related attenuation in the left dorsolateral prefrontal cortex response to a satiating meal using gyral regions-of-interest. J Am Coll Nutr 2009; 28(6): 667-73.
[http://dx.doi.org/10.1080/07315724.2009.10719799] [PMID: 20516266]
[52]
Fabricatore AN, Wadden TA. Obesity. Annu Rev Clin Psychol 2006; 2(1): 357-77.
[http://dx.doi.org/10.1146/annurev.clinpsy.2.022305.095249] [PMID: 17716074]
[53]
Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: State of the art 2008. Brain Stimul 2008; 1(3): 206-23.
[http://dx.doi.org/10.1016/j.brs.2008.06.004] [PMID: 20633386]
[54]
Wassermann EM, Grafman J. Recharging cognition with DC brain polarization. Trends Cogn Sci 2005; 9(11): 503-5.
[http://dx.doi.org/10.1016/j.tics.2005.09.001] [PMID: 16182596]
[55]
Epstein CM, Wassermann EM, Ziemann U. Oxford handbook of transcranial stimulation Oxford Univesity Press: Oxford Handbook 2008; pp. 1-764.
[56]
Val-Laillet D, Aarts E, Weber B, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin 2015; 8: 1-31.
[http://dx.doi.org/10.1016/j.nicl.2015.03.016] [PMID: 26110109]
[57]
Kekic M, McClelland J, Campbell I, et al. The effects of prefrontal cortex transcranial Direct Current Stimulation (tDCS) on food craving and temporal discounting in women with frequent food cravings. Appetite 2014; 78: 55-62.
[http://dx.doi.org/10.1016/j.appet.2014.03.010] [PMID: 24656950]
[58]
Goldman RL, Borckardt JJ, Frohman HA, et al. Prefrontal cortex transcranial Direct Current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite 2011; 56(3): 741-6.
[http://dx.doi.org/10.1016/j.appet.2011.02.013] [PMID: 21352881]
[59]
Fregni F, Orsati F, Pedrosa W, et al. Transcranial direct current stimulation of the prefrontal cortex modulates the desire for specific foods. Appetite 2008; 51(1): 34-41.
[http://dx.doi.org/10.1016/j.appet.2007.09.016] [PMID: 18243412]
[60]
Jauch-Chara K, Kistenmacher A, Herzog N, Schwarz M, Schweiger U, Oltmanns KM. Repetitive electric brain stimulation reduces food intake in humans. Am J Clin Nutr 2014; 100(4): 1003-9.
[http://dx.doi.org/10.3945/ajcn.113.075481] [PMID: 25099550]
[61]
Lapenta OM, Sierve KD, de Macedo EC, Fregni F, Boggio PS. Transcranial direct current stimulation modulates ERP-indexed inhibitory control and reduces food consumption. Appetite 2014; 83: 42-8.
[http://dx.doi.org/10.1016/j.appet.2014.08.005] [PMID: 25128836]
[62]
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129(25) (Suppl. 2): S102-38.
[http://dx.doi.org/10.1161/01.cir.0000437739.71477.ee]
[63]
Susan G. The practical guide identification, evaluation, and treatment of overweight and obesity in adults. Clin Nurse Spec 2002; 16(3): 164.
[64]
O’Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. A systematic review of the clinical effectiveness of orlistat used for the management of obesity. Obes Rev 2004; 5(1): 51-68.
[http://dx.doi.org/10.1111/j.1467-789X.2004.00125.x] [PMID: 14969507]
[65]
Rucker D, Padwal R, Li SK, Curioni C, Lau DCW. Long term pharmacotherapy for obesity and overweight: Updated meta-analysis. BMJ 2007; 335(7631): 1194-9.
[http://dx.doi.org/10.1136/bmj.39385.413113.25] [PMID: 18006966]
[66]
Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest 2003; 111(5): 565-70.
[http://dx.doi.org/10.1172/JCI17953] [PMID: 12618507]
[67]
Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity 2013; 21(11): 2163-71.
[http://dx.doi.org/10.1002/oby.20584] [PMID: 24136928]
[68]
Kaplan LM. Pharmacologic therapies for obesity. Gastroenterol Clin North Am 2010; 39(1): 69-79.
[http://dx.doi.org/10.1016/j.gtc.2010.01.001] [PMID: 20202580]
[69]
Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014; 56(4): 465-72.
[http://dx.doi.org/10.1016/j.pcad.2013.09.005] [PMID: 24438739]
[70]
Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP). Obesity 2012; 20(2): 330-42.
[http://dx.doi.org/10.1038/oby.2011.330] [PMID: 22051941]
[71]
Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377(9774): 1341-52.
[http://dx.doi.org/10.1016/S0140-6736(11)60205-5] [PMID: 21481449]
[72]
Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012; 95(2): 297-308.
[http://dx.doi.org/10.3945/ajcn.111.024927] [PMID: 22158731]
[73]
Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363(3): 245-56.
[http://dx.doi.org/10.1056/NEJMoa0909809] [PMID: 20647200]
[74]
Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: The BLOSSOM trial. J Clin Endocrinol Metab 2011; 96(10): 3067-77.
[http://dx.doi.org/10.1210/jc.2011-1256] [PMID: 21795446]
[75]
Rothman RB, Baumann MH, Dersch CM, et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001; 39(1): 32-41.
[http://dx.doi.org/10.1002/1098-2396(20010101)39:1<32:AID-SYN5>3.0.CO;2-3] [PMID: 11071707]
[76]
Aronne LJ, Powell AG, Apovian CM. Emerging pharmacotherapy for obesity. Expert Opin Emerg Drugs 2011; 16(3): 587-96.
[http://dx.doi.org/10.1517/14728214.2011.609168] [PMID: 21834735]
[77]
Munro JF, MacCuish AC, Wilson EM, Duncan LJP. Comparison of continuous and intermittent anorectic therapy in obesity. BMJ 1968; 1(5588): 352-4.
[http://dx.doi.org/10.1136/bmj.1.5588.352] [PMID: 15508204]
[78]
Saunders KH, Umashanker D, Igel LI, Kumar RB, Aronne LJ. Obesity pharmacotherapy. Med Clin North Am 2018; 102(1): 135-48.
[http://dx.doi.org/10.1016/j.mcna.2017.08.010] [PMID: 29156182]
[79]
Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 2015; 373(1): 11-22.
[http://dx.doi.org/10.1056/NEJMoa1411892] [PMID: 26132939]
[80]
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The scale diabetes randomized clinical trial. JAMA 2015; 314(7): 687-99.
[http://dx.doi.org/10.1001/jama.2015.9676] [PMID: 26284720]
[81]
Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Laparoscopic adjustable gastric banding and other devices for the management of obesity. Circulation 2012; 126(6): 774-85.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.040139] [PMID: 22869859]
[82]
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008; 299(3): 316-23.
[http://dx.doi.org/10.1001/jama.299.3.316] [PMID: 18212316]
[83]
Nguyen NT, Slone JA, Nguyen XMT, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: Outcomes, quality of life, and costs. Ann Surg 2009; 250(4): 631-41.
[http://dx.doi.org/10.1097/SLA.0b013e3181b92480] [PMID: 19730234]
[84]
Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121(10): 885-93.
[http://dx.doi.org/10.1016/j.amjmed.2008.05.036] [PMID: 18823860]
[85]
Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012; 379(9833): 2300-11.
[http://dx.doi.org/10.1016/S0140-6736(12)60401-2] [PMID: 22683132]
[86]
Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: A systematic review. Surg Obes Relat Dis 2010; 6(6): 707-13.
[http://dx.doi.org/10.1016/j.soard.2010.07.011] [PMID: 20947447]
[87]
Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66(9): 618-20.
[http://dx.doi.org/10.1002/bjs.1800660906] [PMID: 497645]
[88]
Billeter AT, Fischer L, Wekerle AL, Senft J, Müller-Stich B. Malabsorption as a therapeutic approach in bariatric surgery. Viszeralmedizin 2014; 30(3): 198-204.
[http://dx.doi.org/10.1159/000363480] [PMID: 26288594]
[89]
Våge V, Gåsdal R, Laukeland C, et al. The biliopancreatic diversion with a duodenal switch (BPDDS): How is it optimally performed? Obes Surg 2011; 21(12): 1864-9.
[http://dx.doi.org/10.1007/s11695-011-0496-9] [PMID: 21874519]
[90]
Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: A randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90(1): 15-22.
[http://dx.doi.org/10.3945/ajcn.2009.27583] [PMID: 19439456]
[91]
Bloomberg RD, Fleishman A, Nalle JE, Herron DM, Kini S. Nutritional deficiencies following bariatric surgery: Whave we learned? Obes Surg 2005; 15: 145-54.
[http://dx.doi.org/10.1381/0960892053268264]
[92]
Gracia JA, Martínez M, Elia M, et al. Obesity surgery results depending on technique performed: Long-term outcome. Obes Surg 2009; 19(4): 432-8.
[http://dx.doi.org/10.1007/s11695-008-9762-x] [PMID: 19002740]
[93]
Elnahas A, Graybiel K, Farrokhyar F, Gmora S, Anvari M, Hong D. Revisional surgery after failed laparoscopic adjustable gastric banding: A systematic review. Surg Endosc 2013; 27(3): 740-5.
[http://dx.doi.org/10.1007/s00464-012-2510-2] [PMID: 22936440]
[94]
Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977; 186(4): 500-9.
[http://dx.doi.org/10.1097/00000658-197710000-00012] [PMID: 907395]
[95]
Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 2010; 92(4): 704-13.
[http://dx.doi.org/10.3945/ajcn.2010.29870] [PMID: 20739420]
[96]
Stroh C, Benedix F, Meyer F, Manger T. Nutrient deficiencies after bariatric surgery -systematic literature review and suggestions for diagnostics and treatment. Zentralbl Chir 2015; 140(4): 407-16.
[http://dx.doi.org/10.1055/s-0032-1328594]
[97]
Schweitzer DH, Posthuma EF. Prevention of vitamin and mineral deficiencies after bariatric surgery: Evidence and algorithms. Obes Surg 2008; 18(11): 1485-8.
[http://dx.doi.org/10.1007/s11695-008-9489-8] [PMID: 18369680]
[98]
Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 2013; 258(4): 628-36.
[http://dx.doi.org/10.1097/SLA.0b013e3182a5034b] [PMID: 24018646]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy